{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2018"],"data_sharing_plan":["IPD Sharing (as of August 2019): No\nDescription: No sharing"],"condition":["Outcome, Fatal","Colorectal Neoplasms"],"disease":["Outcome, Fatal","Colorectal Neoplasms"],"study_type":["Observational"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2280194"],"location":["South Korea"],"study_start_month":["3"],"keyword":["Postoperative complication","Sugammadex","Colorectal surgery"],"repository":["ECRIN MDR"],"study_status":["Completed"],"additional_accession":[]},"is_claimable":false,"name":"The Effect of Sugammadex on the Outcome After Colorectal Cancer Surgery","description":"This study is retrospective study. The purpose of this study is checking the effect of sugammadex on the outcome after colorectal surgery. The outcome is compared among the 2 groups, sugammadex group and non-sugammadex group. The primary parameters of outcome are length of stay, readmission rate, postoperative complications, time interval for first successful oral intake.","dates":{"creation":"2018-03-15"},"accession":"2280194","cross_references":{"ClinicalTrials___gov":["NCT03619759"]}}